======= NAGK ======= == Gene Information == * **Official Symbol**: N/AGK * **Official Name**: N-acetylglucosamine kinase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55577|55577]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UJ70|Q9UJ70]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NAGK&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NAGK|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606828|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Converts endogenous N-acetylglucosamine (GlcNAc), a major component of complex carbohydrates, from lysosomal degradation or nutritional sources into GlcNAc 6-phosphate. Involved in the N-glycolylneuraminic acid (Neu5Gc) degradation pathway: although human is not able to catalyze formation of Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food and must be degraded. Also has ManNAc kinase activity. {ECO:0000269|PubMed:22692205}. |BcrAD BadFG| |N-acetylglucosamine kinase activity| |mannosamine metabolic process| |N-acetylmannosamine metabolic process| |N-acetylneuraminate catabolic process| |UDP-N-acetylglucosamine biosynthetic process| |N-acetylneuraminate metabolic process| |amino sugar catabolic process| |amino sugar biosynthetic process| |UDP-N-acetylglucosamine metabolic process| |N-acetylglucosamine metabolic process| |nucleotide-sugar biosynthetic process| |carbohydrate phosphorylation| |glucosamine-containing compound metabolic process| |nucleotide-sugar metabolic process| |amino sugar metabolic process| |antibiotic catabolic process| |antibiotic metabolic process| |drug catabolic process| |cellular carbohydrate metabolic process| |carbohydrate derivative catabolic process| |carboxylic acid catabolic process| |organic acid catabolic process| |small molecule catabolic process| |carbohydrate metabolic process| |drug metabolic process| |nucleobase-containing small molecule metabolic process| |carbohydrate derivative biosynthetic process| |carboxylic acid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |phosphorylation| |organic cyclic compound biosynthetic process| |ATP binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp212|Phenformin 20μM R05 exp212]]|-2.01| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|-1.76| |[[:results:exp295|Pyronaridine 1μM R06 exp295]]|2.16| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3003 * **Expression level (log2 read counts)**: 5.62 {{:chemogenomics:nalm6 dist.png?nolink |}}